A detailed history of D. E. Shaw & Co., Inc. transactions in Simulations Plus, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 26,671 shares of SLP stock, worth $915,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,671
Holding current value
$915,348
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.46 - $46.86 $654,006 - $1.01 Million
21,471 Added 412.9%
26,671 $853,000
Q2 2024

Aug 14, 2024

SELL
$38.46 - $50.95 $34,614 - $45,855
-900 Reduced 14.75%
5,200 $252,000
Q1 2024

May 15, 2024

SELL
$37.48 - $44.74 $71,212 - $85,006
-1,900 Reduced 23.75%
6,100 $251,000
Q4 2023

Feb 14, 2024

SELL
$33.36 - $45.71 $127,668 - $174,932
-3,827 Reduced 32.36%
8,000 $358,000
Q3 2023

Nov 14, 2023

BUY
$40.03 - $51.51 $118,368 - $152,315
2,957 Added 33.34%
11,827 $493,000
Q2 2023

Aug 14, 2023

BUY
$40.45 - $48.0 $99,911 - $118,560
2,470 Added 38.59%
8,870 $384,000
Q1 2023

May 15, 2023

BUY
$34.96 - $43.94 $3,461 - $4,350
99 Added 1.57%
6,400 $281,000
Q4 2022

Feb 14, 2023

BUY
$36.55 - $51.15 $18,311 - $25,626
501 Added 8.64%
6,301 $230,000
Q3 2022

Nov 14, 2022

BUY
$47.75 - $66.88 $276,950 - $387,904
5,800 New
5,800 $282,000
Q3 2020

Nov 16, 2020

SELL
$57.51 - $75.36 $274,092 - $359,165
-4,766 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$32.91 - $59.82 $46,073 - $83,748
-1,400 Reduced 22.71%
4,766 $285,000
Q1 2020

May 15, 2020

SELL
$26.79 - $38.99 $129,502 - $188,477
-4,834 Reduced 43.95%
6,166 $215,000
Q4 2019

Feb 14, 2020

BUY
$29.07 - $35.63 $44,360 - $54,371
1,526 Added 16.11%
11,000 $320,000
Q3 2019

Nov 14, 2019

BUY
$28.19 - $41.75 $267,072 - $395,539
9,474 New
9,474 $329,000
Q3 2018

Nov 14, 2018

SELL
$17.1 - $23.55 $174,898 - $240,869
-10,228 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$14.65 - $23.75 $149,840 - $242,915
10,228 New
10,228 $228,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $697M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.